Chile has led vaccination efforts in Latin America. Photo: Rodrigo Balladares M./Minsal
Chilean health regulator Instituto de Salud Pública (ISP) gave its approval for the emergency use of the one-dose vaccine manufactured by Chinese firm CanSino Biologics — one week after the government inked a deal to purchase 1.8 million doses. CanSino is the fourth immunizer cleared for use in Chile.
However, regulators added that further studies are necessary to understand whether one shot is indeed enough to protect citizens.
The AD5-nCOV vaccine will only be distributed to citizens aged 18 to 60, as it has yet to be tested on older patients.
Welcome to our Tech Roundup, where we bring you the biggest stories in technology and…
For some time, the decisions of Alexandre de Moraes, justice of Brazil’s Supreme Court and…
Panama was once a part of Colombia. Its canal, a monumental engineering achievement of its…
The specialization trend among corporate board members It is not only a matter of perception:…
Panama will hold its presidential elections on Sunday, months after huge protests saw thousands descend…
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…